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Objective: To compare histopathology and PCR based detection in diagnosis of
experimentally induced toxoplasmosis of RH human strain of the parasite in murine
models.
Methods: A comparison of histopathology and PCR based detection was done to di-
agnose experimentally induced toxoplasmosis in ten inbred swiss albino mice after
intraperitoneal inoculation of 100 tachyzoites of laboratory mantained human RH strain
of the parasite. Tissue samples from lung, liver, spleen, brain, heart and kidney were
taken and processed for histopathological examination while all the samples also were
subjected to PCR, using primers directed to the multicopy of SAG 3 gene, in dublicates.
Results: Histopathology revealed presence of tachyzoites only in liver while along with
lung, liver, spleen and brain tissue yielded desired positive PCR amplicons.
Conclusions: The SAG 3 based PCR is able to diagnose toxoplasmosis in those tissues
which are declared negative by histopathological assay.1. Introduction
Toxoplasma gondii (T. gondii), an obligate intra cellular
coccidian parasite transmitting both by vertical transmission via
mother to newborn [1] and horizontal transmission either by
direct inoculation and/or oral-fecal route [2], is a serious
zoonotic concern in the present time. The pathophysiology of
disease can either be described as acute toxoplasmosis,
occurring mainly with direct inoculation of infective form of
T. gondii (tachyzoites) into the host [3], or chronic
toxoplasmosis, occurring after acute toxoplasmosis as a result
of suppression of tachyzoites division by the host immune
system leading to the formation of tissue-localized cysts (bra-
dyzoites) [4]. Felines are the deﬁnitive hosts, while all non-feline
vertebrates including humans are the intermediate hosts of the
parasite with disseminated tissue infections. Consumption of
undercooked meat of intermediate hosts (mainly pig and sheep)is a major route of transmission of the disease to humans [5]. It
has been estimated that as many as one-third of the world's
population shows serological evidence of infection [6].
Toxoplasmosis causes severe economic losses in terms of
abortions and death of young stock and newborn animals [7]
coupled with its life-threatening consequences both in immu-
nocompromised human patients suffering from acquired im-
mune deﬁciency syndrome (AIDS) and those with organ
transplants [8]. The latent bradyzoites often reverts to
tachyzoites, causing reactivation of acute toxoplasmosis [4]
mainly in the brain tissues [9] ultimately leading to acute
toxoplasmic encephalitis in immunocompromised patients
[10,11] and accounts for around 20% of AIDS related deaths in
the United States [6]. Presence of brain cysts is associated with
various psychiatric disorders such as schizophrenia [12,13]
alongside other brain pathologies in both
immunocompromised and immunocompetent individuals [14,15].
Across the globe, the demonstration of toxoplasmosis in
animals is mainly done by the demonstration of the parasite in
acute cases as well as in aborted fetuses and by serological
means [16]. These methods are time consuming and are basicallyopen access article under the CC BY-NC-ND
Figure 1. Tachyzoites in the peritoneal lavage after Giemsa staining.
Figure 2. Tachyzoite in the liver tissue.
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Other procedures like bioassays [17,18] and isolation in cell
cultures are time consuming and often too much laborious [18].
Histopathology is considered to be a fairly actual indicator of
the presence or absence of infection in the tissue. The advent
of molecular biology has revolutionalized the detection
systems and now even DNA from a single organism of
T. gondii can be used for detection purposes by using PCR
variants [19]. The present paper describes the comparison of
use of SAG 3 gene of T. gondii to detect experimental murine
toxoplasmosis with the traditional histopathological technique.
2. Materials and methods
Ten in bred Swiss albino mice (of either sex, age group 6–8
weeks weighing approximately 22–25 g) were used in the pre-
sent study and subsequently infected intraperitoneally with 102
live virulent human RH strain of T. gondii. The strain was being
maintained through regular passaging in murine model for over
a decade in a cryopreserved stock line in Divisional Protozool-
ogy Laboratory, IVRI. The infected mice were daily monitored
for the development of signs of infection. All the infected mice
started showing characteristic signs of the disease from day 5
post infection (PI). The clinical signs included raised and rough
hair coat, pendulous abdomen, severe ascites, dullness, and
tachypnea marked by resting with fore legs on walls of the
cages, the nozzle of water bottle or on other resting mice. Such
mice were euthanized day 7 PI and the peritoneal ﬂuid was
aspirated after inoculation of 5 mL of sterile phosphate buffered
saline (PBS, pH 7.2) in the peritoneal cavity with due care of
avoiding injury to visceral organs. The peritoneal lavage was
later stained with Giemsa stain to ascertain the presence of free
tachyzoites. The process was repeated until the peritoneal con-
tents were clear. Tissue pieces of lungs, liver, brain, spleen,
kidney and heart were collected and stored in 10% formal saline
solution and send to the Department of Pathology, IVRI, for
routine histopathology. Again small pieces (matchstick head
size) of tissues of these organs were excised and placed in about
150 mL of distilled water and grounded thoroughly with a pestle
and motor. From these grounded samples duplicate samples
were placed in the tubes and were heated in boiling water for
15 min. From these boiled crude samples, 15 mL of the super-
natant was taken and served as the DNA template for PCR
ampliﬁcation. Known positive and negative samples were also
run alongside. The nucleotide sequences of the primers for the
ampliﬁcation of SAG 3 gene [20] were as follows: forward
primer, TS3F 50-ATGCAGCTGTGGCGGCGCAG-30and
reverse, TS3R 50-TTAGGCAGCCACATGCACAAG-30. The
PCR ampliﬁcation was carried out in a 25 mL PCR reaction
mixture consisting of 15 mL of sample, 2.5 mL of 10 × PCR
buffer, 2.5 mL of 2.5 mM dNTP mix, 0.5 mL (1.5 U) of Taq
polymerase and 1 mL each of forward and backward primers.
The ﬁnal volume was made 25 mL by addition of adequate
nuclease free water. The PCR conditions consisted of initial
denaturation of DNA strands at 95 C for 5 min followed by
32 cycles of denaturation at 95 C for 50 s, primer annealing
at 62 C for 75 s and strand elongation at 72 C for 50 s.
Thereafter one cycle of ﬁnal extension of the strands was
given at 72 C for 12 min. The PCR ampliﬁcation was
conﬁrmed by visualization of the PCR products with
appropriate volume of 6 × loading dye on 1.5% agarose gel
stained with ethidium bromide following electrophoresis.3. Results
The peritoneal lavage after Giemsa staining revealed a
number of free tachyzoites (Figure 1). Histopathologically, a
number of miliary necrotic foci characterized by pool of
necrotic cellular debris along with moderate number of
degenerated/intact tachyzoites were found scattered throughout
the liver suggestive of severe necrosis. The tachyzoites were
seen in hepatic parenchymal sinusoidal spaces and along the
portal vessels and central vein (Figure 2). Spleen tissue also
showed a number of necrotic foci disseminated in the white
pulp and red pulp. Lungs showed marked areas of severe ne-
crosis. In brain, few areas of degeneration in the neuropil were
observed. But, no tachyzoites could be detected in spleen,
lungs and brain. The kidneys and heart did not revealed any
abnormal changes. Direct PCR ampliﬁcations were observed in
liver, lungs, spleen and brain tissues. A characteristic speciﬁc
band suggesting ampliﬁcation was seen at 1158 bp distance
that conﬁrmed the presence of T. gondii DNA in these samples
(Figure 3).
Figure 3. Gel showing the desired 1158 bp amplicon of SAG 3.
Lane 1: 100 bp plus ladder, Lane 2: Liver tissue, Lane 3: Lung tissue, Lane
4: Spleen tissue, Lane 5: Brain tissue, Lane 6: Kidney tissue, Lane 7: Heart
tissue.
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It is well known that tachyzoites freely multiply in the lymph
nodes [7]. Hence, the macrophages in the peritoneal ﬂuid account
for presence of tachyzoites. Similarly, lymphoid tissue drained
to liver and spleen account for ampliﬁcation in these tissues.
Brain and lungs are found to be centers of tissue reactions
caused due to acute toxoplasmosis [21]. The kidney and heart
samples did not show any ampliﬁcation and it could be
attributed to absence of tachyzoites in these tissues owing to
acute phase of infection and tachyzoites did not got enough
time to reach to these organs, later get converted to
bradyzoites and actually get settled in these tissues as
pseudocysts.
PCR is a highly sensitive, speciﬁc and rapid technique for
detecting T. gondi [22,23]. The ultimate signiﬁcance of PCR based
detection of toxoplasmosis is that PCR can detect the DNA of
parasites even when the tissues available for testing are in state
of decomposition; in contrast in histopathology it is quite
difﬁcult to identify the necrosed tachyzoites in the regions of
marked generalized necrosis of the parent tissues induced by
tachyzoites themselves. Moreover, the size of the sample
analysed is very important in the detection by histopathology
and it is quite possible that the parasitic stage in the sample to
be tested is either low or sparse and show focal distribution in
the tissues or it may be all together dead. But PCR will give
ampliﬁcation even if the parasitic stage is dead [24] and/or very
less in number. PCR can even detect 0.1 pg of DNA [19] and
even a very few tachyzoites are sufﬁcient in accurate diagnosis
no matter if they are living or dead.
A wide range of gene targets like B1 gene [16–18], Tox4 and
Tox5 genes [25] are already been used for the PCR based
diagnosis of toxoplasmosis from time over and over again. All
these gene targets are having their own advantages and
limitations. Most of the times, these are either present in either
one of the infective stage of the parasite and thereby their
presence is affected by the course of the infection [23]. Surface
antigen 3, a glycosylphosphatidylinisotol anchored membrane
bound protein, commonly found on both the developmental
stages of parasite viz. tachyzoites and bradyzoites [26,27], is
associated with parasite binding with host heparin sulfate
proteoglycans and thereby, facilitating the parasite attachment
to the host cell-surface proteoglycans [28]. Hence, thismolecule was selected so as it can detect tachyzoites in acute
infections as well as tissue cysts in form of bradyzoites in
chronic cases. Nevertheless, considering toxoplasmosis, a
signiﬁcant emerging zoonotic problem, the ﬁndings reported
herein have undoubtedly opened newer frontier of research. It
would be interesting to precisely investigate through well
planned experimental studies to elucidate effective well
planned research aiming at SAG 3 molecule to be used as a
potent candidate both for human and animal studies for
diagnosis through PCR. Further detailed research in all these
regards is there by warranted. There is an utmost need for the
development of a highly sensitive test for the accurate
diagnosis of toxoplasmosis as the disease is widely prevalent
both in animals [6,29] and humans [12–15] worldwide.
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